Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (GLENMARK PHARMACEUTICALS INC., USA)

View source ↗

Summary

FDA approved a supplemental application for prochlorperazine maleate filed by Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCHLORPERAZINE MALEATE (prochlorperazine maleate)

Snippet

SUPPL AP for PROCHLORPERAZINE MALEATE (PROCHLORPERAZINE MALEATE)